Cancer: An Overview


  • Nidhi Tyagi ITS College of Pharmacy, Delhi-Meerut Road Muradnagar, Ghaziabad, India
  • Ganesh N. Sharma ITS College of Pharmacy, Delhi-Meerut Road Muradnagar, Ghaziabad, India
  • Birendra Shrivastava ITS College of Pharmacy, Delhi-Meerut Road Muradnagar, Ghaziabad, India
  • Nitin Chaudhary School of Pharmaceutical Science, Jaipur National University, Jaipur, India
  • Nitendra Sahu School of Pharmaceutical Science, Jaipur National University, Jaipur, India



Cancer, metastasis, benign tumor


Cancer is the second leading causes of deaths in western countries after heart disease. In US alone more than one million people are diagnosed with cancer annually and more than half result in death. Cancer is a medical condition where abnormal cells in body divided without any control. Cancers cells do not respond normally to the body’s control mechanism, so they divide excessively and invade the neighboring tissues. Cancer starts when a normal cell is instantly detected by body immune system. However, if the abnormal cells remain at the original site, it will result in the less severe condition termed as benign tumor. Benign tumor can be completely removed by surgery and pose little threat. Malignant tumors have capability to enter the blood stream invading other tissues and disrupting the normal function of various systems in the body. They are difficult to treat may become life threatening. Cancer cells can spread to distinct locations from the original site by a process called metastasis.


Download data is not yet available.


Medical News Today – What is Cancer? Available from- http://www/ Last accessed December 2016.

National Cancer Institute. Available from – Last accessed December 2016

Cancer Research UK. Available from – Last accessed December 2016.

Cancer Research UK. Available from – Last accessed December 2016.

World Cancer Research Fund. Available from – Last accessed December 2016.

American Cancer Society. Available from – Last accessed December 2016.

Macmillan Cancer Support. Available from – Last accessed December 2016.

Weber W.P., Zanetti R. and Langer I., “Mammotome: Less invasive than ABBI with similar accuracy for early breast cancer detection”, World Journal of Surgery 2005;29: 495-499.

Jemal A., Siegel R. and Ward E., “Cancer statistics”, Ca-a Cancer Journal for Clinicans 2006;56: 106-130.

Merlo L.M.F., Pepper J.W., Reid B.J. and Maley C.C., “Cancer as an evolutionary and ecological process”, Nature Reviews Cancer 2006;6: 924-935.[View in PubMed]

Butler T.P. and Gullino P.M., “Quantitation of cell shedding into efferent blood of mammary adenocarcinoma”, Cancer Research 1975;35: 512-516.[View in PubMed]

Fidler I.J., “Metastasis – Quantitative analysis of distribution and fate of tumor emboli labled with I-125-5-iodo-2-deoxyruidine”, Journal of the National Cancer Institute 1990; 45:773.

Wyckoff J.B., Jones J.G., Condeelis J.S. and Segall J.E., “A critical step in metastasis: In vivo analysis of intravasation at the primary tumor”, Cancer Research 2000;60: 2504-2511.[View in PubMed]

Kaplan R.N., Riba R.D. and Zacharoulis S., “VEGFR1- positive hermatopoietic bone marrow progenitors initiate the pre-metastatic niche”, Nature 2005;438: 820-827.[View in PubMed]

Paget S., “The distribution of secondary growths in cancer of the breast”, Cancer metastasis reviews 1989;8:98-101.[View in PubMed]

James E., “Neoplastic Disease: A treatise on Tumors”, Philadelphia London, W.B. Saunders company 1928.

Hart I.R. and Fidler I.J., “Role of organ selectively in the determination of metastatic patterns of B-16 melanoma”, Cancer Research 1980;40: 2281-2287.[View in PubMed]

Weiss L., “Comments on hematogenous metastatic patterns in human as revealed by autopsy”, Clinical & Experimental Metastasis 1992;10: 191-199.

Weiss L. and Harlos J.P., “The validity of negative necropsy reports for metastases in solid organs”, Journal of Pathology 1986;148: 203-206.

Welch D.R., “Technical considerations for studying cancer metastasis in vivo”, Clinical & Experimental Metastasis 1997;15: 272-306.

Steeg P.S., “Tumor metastasis: mechanistic insights and clinical challenges”, Nature Medicine 2006;12: 895-904.

Unnikrishnan M.C. and Ramadasan K., “Cytotoxicity of extracts of spices to cultured cells”, Nutr Cancer 1998;11:251-257.

Russo A., Piovano M. and Lombardo L., “Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells”, Anti-Cancer Drugs 2006;17: 1163-1169.

Mossman T., “Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays”, J. Immunol Methods 1983; 65:55-63.

Economou M. A., Andersson S. and Vasilcanu D., “Oral picropodophullin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma”, Acta Ophthalmologica2008; 86:35-41.

Skehan P., Storeng R. and Scudiero D., “New colorimetric cytotoxicity assay for anticancer drug screening”, J Natl Cancer Inst. 1990;82:1107-1112.

Devi P.U., Rao B.S.S. and Solomon F.E., “Effect of plumbagin on the radiation induced cytogenetic and cell cycle changes in mouse Ehrlich ascites carcinoma in vivo”, Indian J. Exp. Biol. 1998;36:891-895.



How to Cite

Tyagi, N. ., Sharma, G. N. ., Shrivastava, B. ., Chaudhary, N. ., & Sahu, N. (2017). Cancer: An Overview. International Journal of Research and Development in Pharmacy & Life Sciences, 6(5), 2740 - 2747.